FDA InspectionCSL Plasma Inc.
CSL Plasma Inc. – FDA Inspection, Feb 7, 2025
Record Details
This FDA Inspection record concerns CSL Plasma Inc., with an inspection on February 7, 2025, issued by the Atlanta District Office, covering human drugs.
ID · 5482c656-8b42-4afe-83b5-e77408c9ddb1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1260233
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CSL Plasma Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 17, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 18, 2009 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
Comes with the profile
KRA (KeyPedia Risk Analysis)
How likely the FDA is to take enforcement action in the next 12 months.
Example18-month trend
Form 483 · February 7, 2025
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every CSL Plasma Inc. document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA